Introduction Dyspareunia has been called the neglected symptom of endometriosis and is
underexplored in clinical and research contexts. Understanding the physical experience and …

Introduction Dyspareunia has been traditionally divided into superficial (introital) dyspareunia
and deep dyspareunia (pain with deep penetration). While deep dyspareunia can coexist …

A key clinical problem is identifying the patient with endometriosis whose pain is complicated
by central nervous system sensitization, where conventional gynecologic treatment (eg, …

PURPOSE Access to family planning health services in Canada has been historically
inadequate and inequitable. A potential solution appeared when Health Canada approved …

Introduction Deep dyspareunia is a cardinal symptom of endometriosis, and as many as 40%
of people with this condition experience comorbid superficial dyspareunia. Aim To …

Objective This study sought to identify factors independently associated with a negative
impression of the medical profession in patients with endometriosis who were presenting to a …

Genetic studies associate killer cell immunoglobulin-like receptors (KIRs) and their HLA
class I ligands with a variety of human diseases. The basis for these associations and the …

… An accompanying podcast is available in the Supplementary Data, in which the authors
Dr Madeleine Ennis and Kate Wahl discuss their research on how family planning care and …

Background Since Canadian drug regulatory approval of mifepristone for medical abortion
in 2015 and its market availability in January 2017, the role of pharmacists in abortion …

Background Endometriosis-associated deep dyspareunia is associated with reduced
sexual quality of life, lower self-esteem, and impaired sexual function. Objective The primary …